307 related articles for article (PubMed ID: 14582465)
21. Diabetes mellitus, obesity, and hepatic steatosis.
Youssef W; McCullough AJ
Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
[TBL] [Abstract][Full Text] [Related]
22. The emerging problem of nonalcoholic steatohepatitis (NASH).
Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and interpretation of steatosis and steatohepatitis.
Burt AD; Mutton A; Day CP
Semin Diagn Pathol; 1998 Nov; 15(4):246-58. PubMed ID: 9845426
[TBL] [Abstract][Full Text] [Related]
24. [Non-alcoholic steatohepatitis].
Alvarez-Martínez H; Pérez-Campos E
Rev Gastroenterol Mex; 2002; 67(2):118-25. PubMed ID: 12214335
[TBL] [Abstract][Full Text] [Related]
25. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
26. [Non-alcoholic steato-hepatitis].
Linhart HG
Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
28. [Steatosis and steatohepatitis in diabetic patient].
Hůlek P; Dresslerová I
Vnitr Lek; 2011 Apr; 57(4):364-7. PubMed ID: 21612059
[TBL] [Abstract][Full Text] [Related]
29. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
Charlton M; Kasparova P; Weston S; Lindor K; Maor-Kendler Y; Wiesner RH; Rosen CB; Batts KP
Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic fatty liver disease of obesity.
Sachdev MS; Riely CA; Madan AK
Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
[TBL] [Abstract][Full Text] [Related]
31. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
[TBL] [Abstract][Full Text] [Related]
32. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
33. [Non-alcoholic steatohepatitis: a childhood case].
Tokodi I; Molnár A; Reiber I; Simon G
Orv Hetil; 2002 Aug; 143(32):1899-903. PubMed ID: 12221996
[TBL] [Abstract][Full Text] [Related]
34. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
Mori S; Yamasaki T; Sakaida I; Takami T; Sakaguchi E; Kimura T; Kurokawa F; Maeyama S; Okita K
J Gastroenterol; 2004; 39(4):391-6. PubMed ID: 15168253
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of non-alcoholic steatohepatitis.
McClain CJ; Mokshagundam SP; Barve SS; Song Z; Hill DB; Chen T; Deaciuc I
Alcohol; 2004 Aug; 34(1):67-79. PubMed ID: 15670668
[TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic steatohepatitis: what we know in the new millennium.
Harrison SA; Kadakia S; Lang KA; Schenker S
Am J Gastroenterol; 2002 Nov; 97(11):2714-24. PubMed ID: 12425538
[TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic steatohepatitis.
Jansen PL
Neth J Med; 2004; 62(7):217-24. PubMed ID: 15554595
[TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
[TBL] [Abstract][Full Text] [Related]
40. [Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)].
Podymova SD
Ter Arkh; 2006; 78(4):32-8. PubMed ID: 16821419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
